Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 25, Issue 4, 1999, Pages 307-315

  Wolf, Nancy G ^e   Abdul Karim, Fadi W ^a   Farver, Carol ^b   Schröck, Evelin ^c   Du Manoir, Stanislas ^c   Schwartz, Stuart ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER GROWTH; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; OVARY TUMOR; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR PROMOTION;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, NEOPLASM; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; PLOIDIES; PRECANCEROUS CONDITIONS;

ANIMALIA;

EID: 0032812322     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199908)25:4<307::AID-GCC1>3.0.CO;2-1     Document Type: Article

References (43)

1. Arnold N, Hägele L, Walz L, Schempp W, Pfisterer J, Bauknecht T, Kiechle M. 1996. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16:46-54.
2. Arzimanoglou II, Lallas T, Osborne M, Barber H, Gilbert F. 1996. Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis 17:1799-1804.
3. Bell DA, Scully RE. 1994. Early de novo ovarian carcinoma: a study of fourteen cases. Cancer 73:1859-1864.
4. Berchuck A, Kohler MF, Hopkins MP, Humphrey PA, Robboy SJ, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC. 1994. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol 52:232-236.
5. Brock J-AK, Liu W-H, Smith ST, Young SR. 1996. Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization. Genes Chromosomes Cancer 16:120-129.
6. Chenevix-Trench G, Kerr J, Hurst T, Shih Y-C, Purdie D, Bergman L, Friedlander M, Sanderson B, Zournazi A, Coombs F, Leary JA, Crawford E, Shelling AN, Cooke I, Ganesan TS, Searle J, Choi C, Barrett JC, Khoo S-K, Ward B. 1997. Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations. Genes Chromosomes Cancer 18:75-83.
7. Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, Theillet C. 1996. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer 74:1984-1989.
8. Deger RB, Faruqi SA, Noumoff JS. 1997. Karyotypic analysis of 32 malignant epithelial ovarian tumors. Cancer Genet Cytogenet 96:166-173.
9. Diebold J, Deisenhofer I, Baretton GB, Blasenbreu S, Suchy B, Schneiderbanger K, Meier W, Haas CJ, Löhrs U. 1996. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas. Lab Invest 75:473-485.
10. du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T. 1993. Detection of complete and partial chromosome gains and losses by comparative genomic hybridization. Hum Genet 90:590-610.
11. du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. 1995. Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
12. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. 1996. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
13. Houldsworth J, Chaganti RSK. 1994. Comparative genomic hybridization: an overview. Am J Pathol 145:1253-1260.
14. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW. 1995. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55:6172-6180.
15. Izutsu T, Kudo T, Shoji T, Nishiya I. 1996. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors. J Obstet Gynaecol Res 22:541-549.
16. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L. 1993. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
17. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM. 1994. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
18. Kiechle-Schwarz M, Bauknecht T, Schmidt J, Walz L, Pfleiderer A. 1995. Recurrent cytogenetic aberrations in human ovarian carcinomas. Cancer Detect Prev 19:234-243.
19. Link CJ Jr, Kohn E, Reed E. 1996a. The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: epidemiologic, pathologic, and molecular aspects. Gynecol Oncol 60:347-354.
20. Link CJ, Reed K, Sarosy G, Kohn EC. 1996b. Borderline ovarian tumors. Am J Med 101:217-225.
21. Mitelman F. 1994. Catalog of Chromosome Aberrations in Cancer, 5th ed. New York: Wiley-Liss, Inc.
22. Nacheva EP, Grace CD, Bittner M, Ledbetter DH, Jenkins RB, Green AR. 1998. Comparative genomic hybridization: a comparison with molecular and cytogenetic analysis. Cancer Genet Cytogenet 100:93-105.
23. Pejovic T, Heim S, Örndal C, Jin Y, Mandahl N, Willén H. Mitelman F. 1990. Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors. Cancer Genet Cytogenet 49:95-101.
24. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Flodérus U-M, Furgyik S, Helm G, Himmelmann A, Willén H, Mitelman F. 1992. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
25. Pejovic T, Iosif CS, Mitelman F, Heim S. 1996. Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1). as nonrandom features. Cancer Genet Cytogenet 92:95-98.
26. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB. 1993. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733-741.
27. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi O-P, Waldman FM, Gray JW, Pinkel D. 1995. Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26.
28. Powell DE, Puls L, van Nagell J Jr. 1992. Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur? Hum Pathol 23:846-847.
29. Ried T, Knutzen R, Steinbeck R, Blegen H, Schröck E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245.
30. Roberts CG, Tattersall MHN. 1990. Cytogenetic study of solid ovarian tumors. Cancer Genet Cytogenet 48:243-253.
31. Sasano H, Garrett CT, Wilkinson DS, Silverberg S, Comerford J, Hyde J. 1990. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. Hum Pathol 21:382-391.
32. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Rüschoff J, Hofstädter F. 1995. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55:6002-6005.
33. Scully RE. 1993. Ovary, In: Henson DE, Albores-Saavedra J, editors. Pathology of Incipient Neoplasia, 2nd ed. Philadelphia: WB Saunders, p. 283-300.
34. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR. 1997a. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20:320-328.
35. Sonoda G, du Manoir S, Godwin AK, Bell DW, Liu Z, Hogan M, Yakushiji M, Testa JR. 1997b. Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization. Genes Chromosomes Cancer 18:115-125.
36. Sood AK, Buller RE. 1996. Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 13:2499-2504.
37. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR, Mok SC. 1996. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res 56:2501-2505.
38. Tapper J, Bützow R, Wahlström T, Seppälä M, Knuutila S. 1997. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br J Cancer 75:1782-1787.
39. Tharapel SA, Qumsiyeh MB, Photopulos G. 1991. Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors. Cancer Genet Cytogenet 55:89-96.
40. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS. 1994a. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer 10:262-266.
41. Thompson FH, Emerson J, Alberts D, Liu Y, Guan X-Y, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powell D, Trent J. 1994b. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45.
42. Wolf NG, Abdul-Karim FW, Schork NJ, Schwartz, S. 1996. Origins of heterogeneous ovarian carcinomas: a molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components. Am J Pathol 149:511-520.
43. Yang-Feng TL, Li SB, Leung WY, Carcangiu ML, Schwartz PE. 1991. Trisomy 12 and K-ras-2 amplification in human ovarian tumors. Int J Cancer 48:678-681.